BioSpace News Archive

PharmaCyte Biotech, Inc. (OTCQB: PMCB), announced today an update on the completed tests that are part of the U.S. Food and Drug Administration (FDA) required “release testing” related to the company’s first manufactured batch of its clinical trial product to be used in its planned Phase 2b clinical trial in locally advanced, inoperable pancreatic cancer (LAPC).

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases, today announced that company management will participate at the Evercore ISI 2nd Annual HealthCONx Conference

LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced it is hosting a breakfast panel featuring senior health and investment executives titled, An Unvarnished Look at J.P. Morgan Week 2020, from 8:30 to 10:30 a.m. on Thursday, Dec. 19, 2019 at the Royal Sonesta in Cambridge, MA.